title: Update in Interstitial Lung Disease 2014.
authors.forename: Elizabeth A
authors.initials: EA
authors.lastname: Belloli
authors.forename: Fernando J
authors.initials: FJ
authors.lastname: Martinez
authors.forename: Kevin R
authors.initials: KR
authors.lastname: Flaherty
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D004318:Doxycycline / Q000627:therapeutic use; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D006801:Humans; D054990:Idiopathic Pulmonary Fibrosis / Q000175:diagnosis / Q000188:drug therapy* / Q000378:metabolism; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007211:Indoles / Q000627:therapeutic use*; D017563:Lung Diseases, Interstitial / Q000175:diagnosis / Q000188:drug therapy / Q000378:metabolism; D018192:Lymphangioleiomyomatosis / Q000175:diagnosis / Q000188:drug therapy / Q000378:metabolism; D011728:Pyridones / Q000627:therapeutic use*; D017565:Sarcoidosis, Pulmonary / Q000175:diagnosis / Q000188:drug therapy / Q000378:metabolism; D020123:Sirolimus / Q000627:therapeutic use; D012907:Smoking; D014057:Tomography, X-Ray Computed; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D000900:Anti-Bacterial Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D004791:Enzyme Inhibitors; D007166:Immunosuppressive Agents; D007211:Indoles; D011728:Pyridones; D014409:Tumor Necrosis Factor-alpha; C093844:pirfenidone; C530716:nintedanib; D004318:Doxycycline; D020123:Sirolimus